| Model Number |
CNW0T4 |
| Medical Device Problem Code |
Material Opacification (1426)
|
| Health Effect - Clinical Codes |
Blurred Vision (2137); No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
06/03/2025
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
A health care professional reported that, after intraocular lens (iol) implantation surgery, during first day post operative review, the iol was found to be noticeably opaque.The surgeon will continue to monitor the patient for any possible adverse effects post operatively.There was no patient harm.
|
| |
|
Additional Manufacturer Narrative
|
|
The product was not returned for analysis; the lens remains implanted.Complaint history and product history records were reviewed and documentation indicated the product met release criteria.Root cause has not been identified.The manufacturer internal reference number is: (b)(4).
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information was provided in b.5., h.3., h.6.And h.11.The product was not returned for analysis.Only photo was returned.The returned photo appears to show a close up image of the eye.The intra ocular lens (iol) cannot be observed in the returned photo.There appears to be blue marks observed against the black pupil of the eye.The root cause is deemed to be manufacturing related.Complaints have been received describing that lenses were reported by doctors for the presence of a ¿polychromatic sheen¿ visible.The cause of ¿sheen¿ or ¿film-like¿ appearance is a result of a change in the positioning of the iol during the manufacturing process and is not associated with any foreign material or contamination.The observation has been reported clinically and confirmed in laboratory settings to disappear over time following implantation.The appearance is a result of a temporary change in the surface of the iol that occurs during the delivery process, which is only visible under certain orientations and illumination settings.This resolves once the iol is delivered and exposed to body temperature over time.There are no adverse impacts or lasting effects on the iol or the patient.Based on the results of the product investigation and testing, it was confirmed there are no adverse events or clinical impact on vision associated with this finding.Based on the results from the product history record, the products met release criteria.The manufacturer internal reference number is: (b)(4).
|
| |
|
Event or Problem Description
|
|
Additional information was received stating that, the hazy was still there but a little better.
|
| |
|
Search Alerts/Recalls
|